|
|||||
|
|
Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia |
|
| Authors: | Louise Geddes Jenny Iversen Handan Wand Lisa Maher |
| Affiliation: | The Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, NSW, Australia |
| Abstract: | |
| Keywords: | Buprenorphine buprenorphine–naloxone injectable opioid treatment methadone opioid agonist therapy people who inject drugs treatment discontinuation |